DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstrating promising results of neutralizing the virus. The October JOLTS numbers also we ... Show More
Oct 22
The GENIUS Act Is Here — What Changes for Stablecoins? w/ Jonathan Gould, U.S. Comptroller of the Currency
Ash Bennington sits down with Jonathan Gould, U.S. Comptroller of the Currency, to break down the OCC’s final rule implementing its portion of the GENIUS Act. Gould explains how the new federal framework will regulate payment stablecoin issuers, including reserve requirements, re ... Show More
24m 53s
Oct 19
Is Inflation About to Derail the Rally? with Andreas Steno | Macro Mondays - Oct. 19, 2026
Andreas Steno of Steno Research is flying solo on this week's Macro Mondays, breaking down the latest inflation signals and what they mean for the market outlook. With energy prices and input costs rising, is another inflation shock on the horizon — and could Kevin Warsh be focus ... Show More
31m 55s
Nov 2021
Job Creation Roars Back, Labor Secretary Marty Walsh, Pfizer’s Covid-19 Pill, Peloton Gets Smacked
Carl Quintanilla and Jim Cramer begin the morning discussing Pfizer’s announcement that its experimental COVID-19 pill reduces the risk of death and hospitalization by 89%. Shares of Pfizer surging on the news. Plus, job creation roaring back in October as payrolls rose by 531,0 ... Show More
42m 52s
Nov 2020
COVID-19 Vaccine Optimism, Business Leaders' Message To President Trump, And Retail Stocks' Big November Rally
<p>Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no ser ... Show More
42m 24s
Dec 2021
After the Rally: Pfizer's COVID Booster vs. Omicron, Apple's Record Run, The EV Battle Intensifies and Stitch Fix Plummets
The morning after the best day for both the S&P 500 and Nasdaq since March, Carl Quintanilla, Jim Cramer and David Faber led off the show with news out of Pfizer and BioNTech: Data shows their COVID-19 vaccine neutralized the omicron variant with three shots. The anchors discusse ... Show More
43m 51s
May 2021
Pfizer’s Results, What’s Next for Retail & Restaurants, The High Bar for CRISPR & More
<p>It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Bi ... Show More
58m 18s
Feb 2021
U.S. closer to first single-dose vaccine after Johnson & Johnson version clears major FDA hurdle; Dem divide on Biden OMB nominee, push for $15 minimum wage; Sheriff: Woods’ survival from crash “nothing short of a miracle”; First interview with Biden’s Veterans Affairs Secretary
Promising signs in pandemic: vaccine progress, cases and hospitalizations down, deaths slow in new estimate; WH: 3-4 million doses of J&J vaccine to go out next week if FDA grants emergency use; Moderna testing vaccine boosters to combat South Africa variant; WH: J&J’s production ... Show More
44m 36s